ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Phase 2 Clinical Trial Of A Recombinant Adeno-Associated Virus (RAAV) Alpha-1 Antitrypsin (AAT) Gene Therapy Vector
Mapping Intimacies
◽
10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2428
◽
2011
◽
Author(s):
Terence Flotte
◽
Bruce Trapnell
◽
Margaret Humphries
◽
Brenna Carey
◽
Roberto Calcedo
◽
...
Keyword(s):
Clinical Trial
◽
Gene Therapy
◽
Phase 2
◽
Adeno Associated Virus
◽
Gene Therapy Vector
◽
Phase 2 Clinical Trial
◽
Alpha 1 Antitrypsin
Download Full-text
Related Documents
Cited By
References
49. Transgene T Cell Response in a Phase 2 Clinical Trial of rAAV1.Alpha-1 Antitrypsin Gene Therapy Vector: CD8+ Mediated and HLA C*05 Restricted
Molecular Therapy
◽
10.1016/s1525-0016(16)35853-1
◽
2012
◽
Vol 20
◽
pp. S20
Keyword(s):
Clinical Trial
◽
Gene Therapy
◽
T Cell
◽
Cell Response
◽
T Cell Response
◽
Phase 2
◽
Gene Therapy Vector
◽
Phase 2 Clinical Trial
◽
Alpha 1 Antitrypsin
Download Full-text
Clinical Evaluation of a Recombinant Adeno-Associated Virus (rAAV) Alpha-1 Antitrypsin (AAT) Gene Therapy Vector.
10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a2908
◽
2009
◽
Author(s):
J Chulay
◽
M Brantly
◽
L Wang
◽
C Mueller
◽
M Humphries
◽
...
Keyword(s):
Gene Therapy
◽
Clinical Evaluation
◽
Adeno Associated Virus
◽
Gene Therapy Vector
◽
Alpha 1 Antitrypsin
Download Full-text
Choroideremia Gene Therapy Phase 2 Clinical Trial: 24-Month Results
American Journal of Ophthalmology
◽
10.1016/j.ajo.2018.09.012
◽
2019
◽
Vol 197
◽
pp. 65-73
◽
Cited By ~ 46
Author(s):
Byron L. Lam
◽
Janet L. Davis
◽
Ninel Z. Gregori
◽
Robert E. MacLaren
◽
Aniz Girach
◽
...
Keyword(s):
Clinical Trial
◽
Gene Therapy
◽
Phase 2
◽
Phase 2 Clinical Trial
Download Full-text
232. Alpha-1 Antitrypsin (AAT) Expression 1 Year after IM Administration of rAAV1-CB-hAAT in a Phase 2 Clinical Trial
Molecular Therapy
◽
10.1016/s1525-0016(16)36036-1
◽
2012
◽
Vol 20
◽
pp. S231-S232
Keyword(s):
Clinical Trial
◽
Phase 2
◽
Phase 2 Clinical Trial
◽
Alpha 1 Antitrypsin
Download Full-text
Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial
SKIN The Journal of Cutaneous Medicine
◽
10.25251/skin.3.supp.9
◽
2019
◽
Vol 3
◽
pp. S9
Author(s):
Zoe Draelos
◽
Fran Cook-Bolden
◽
Lawrence Green
◽
Eric Guenin
◽
Gina Martin
◽
...
Keyword(s):
Clinical Trial
◽
Patient Reported Outcomes
◽
Phase 2
◽
Patient Reported
◽
Phase 2 Clinical Trial
Abstract not available.
Download Full-text
Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
Case Medical Research
◽
10.31525/ct1-nct04283669
◽
2020
◽
Author(s):
Keyword(s):
Clinical Trial
◽
Neurofibromatosis Type
◽
Neurofibromatosis Type 2
◽
Vestibular Schwannomas
◽
Phase 2
◽
Phase 2 Clinical Trial
Download Full-text
Faculty Opinions recommendation of Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1047842.497861
◽
2006
◽
Author(s):
David Sullivan
Keyword(s):
Clinical Trial
◽
Plasmodium Falciparum
◽
Combination Therapy
◽
Falciparum Malaria
◽
Plasmodium Falciparum Malaria
◽
Phase 2
◽
Phase 2 Clinical Trial
◽
Uncomplicated Plasmodium Falciparum Malaria
◽
Randomized Phase 2
Download Full-text
Faculty Opinions recommendation of Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.727784209.793552909
◽
2018
◽
Author(s):
Warren A Chow
Keyword(s):
Clinical Trial
◽
Macrophage Infiltration
◽
Phase 2
◽
Pathway Activation
◽
Phase 2 Clinical Trial
Download Full-text
Phase 2 Clinical Trial of Intraoral Grafting of Human Tissue-Engineered Oral Mucosa
10.21236/ada591622
◽
2013
◽
Author(s):
Stephen E. Feinberg
Keyword(s):
Clinical Trial
◽
Oral Mucosa
◽
Human Tissue
◽
Phase 2
◽
Phase 2 Clinical Trial
Download Full-text
A Descriptive Cost‐Analysis of MYX.1/MCRN003, a Phase 2 Clinical Trial Evaluating High‐dose Weekly Carfilzomib, Cyclophosphamide, and Dexamethasone in Relapsed and Refractory Multiple Myeloma
European Journal Of Haematology
◽
10.1111/ejh.13671
◽
2021
◽
Author(s):
Bethany E. Monteith
◽
Christopher P. Venner
◽
Matthew C. Cheung
◽
Joe Pater
◽
Lois Shepherd
◽
...
Keyword(s):
Clinical Trial
◽
Multiple Myeloma
◽
Cost Analysis
◽
High Dose
◽
Phase 2
◽
Refractory Multiple Myeloma
◽
Phase 2 Clinical Trial
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close